C

CytoAgents

13 employees

CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Public Health
Pharmaceutics
COVID19
Cytokine
Virology
Medical Cost Containment
Life Sciences
Medical Technology
Health Care
Coronavirus
Healthcare Management
Infectious
Influenza
Immunotherapy
Patient Safety
Medical
Drug Development

Date founded

2018

Funding rounds raised

Total raised

$7M

from 10 investors over 10 rounds

C

CytoAgents raised $7M on May 12, 2023

Investors: PCG Capital and BlueTree Allied Angels

C

CytoAgents raised $100K on July 30, 2021

Investors: Innovation Works

C

CytoAgents raised $2M on March 10, 2021

Investors: National Institutes of Health

C

CytoAgents raised $50K on January 20, 2021

Investors: Innovation Works

C

CytoAgents raised $250K on July 2, 2020

Investors: Richard King Mellon Foundation

C

CytoAgents raised $1.6M on May 13, 2020

Investors: National Institutes of Health

C

CytoAgents raised undisclosed on April 30, 2020

Investors: EQx Fund

C

CytoAgents raised $100K on January 17, 2020

Investors: Innovation Works

C

CytoAgents raised undisclosed on January 1, 2019

Investors: Boston Harbor Angels Inc.

FAQ